Axogen Valuation
| AXGN Stock | USD 11.28 0.35 3.01% |
At this time, the firm appears to be undervalued. Axogen Inc shows a prevailing Real Value of $14.79 per share. The current price of the firm is $11.28. Our model approximates the value of Axogen Inc from analyzing the firm fundamentals such as Current Valuation of 560.11 M, return on equity of -0.0722, and Profit Margin of (0.04) % as well as examining its technical indicators and probability of bankruptcy. Key fundamental drivers impacting Axogen's valuation include:
Price Book 4.8758 | Enterprise Value | Enterprise Value Ebitda 63.7286 | Price Sales 2.641 | Forward PE 41.841 |
Undervalued
Today
Please note that Axogen's price fluctuation is somewhat reliable at this time. Calculation of the real value of Axogen Inc is based on 3 months time horizon. Increasing Axogen's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Axogen is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Axogen Stock. However, Axogen's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 11.28 | Real 14.79 | Target 24.43 | Hype 11.04 | Naive 12.04 |
The intrinsic value of Axogen's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Axogen's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Axogen Inc helps investors to forecast how Axogen stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Axogen more accurately as focusing exclusively on Axogen's fundamentals will not take into account other important factors: Traditionally, analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use Axogen's intrinsic value based on its ongoing forecasts of Axogen's financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against Axogen's closest peers.
Axogen Cash |
|
Axogen Valuation Trend
Knowing Axogen's actual value is paramount for traders when making sound investment determinations. Using both Axogen's enterprise value as well as its market capitalization is the best way to estimate the value of the company and is usually enough for investors to make market timing decisions.
Axogen Total Value Analysis
Axogen Inc is presently forecasted to have valuation of 560.11 M with market capitalization of 513.74 M, debt of 68.69 M, and cash on hands of 58.03 M. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Axogen fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
560.11 M | 513.74 M | 68.69 M | 58.03 M |
Axogen Investor Information
About 86.0% of the company shares are held by institutions such as insurance companies. The book value of Axogen was presently reported as 2.32. The company recorded a loss per share of 0.16. Axogen Inc last dividend was issued on the 27th of January 2010. The entity had 105:100 split on the 11th of July 1994. Based on the analysis of Axogen's profitability, liquidity, and operating efficiency, Axogen Inc may be sliding down financialy. It has an above-average probability of going through some form of financial hardship next quarter.Axogen Asset Utilization
The concept of asset utilization usually refers to the revenue earned for every dollar of assets a company currently reports. The recent return on assets of Axogen suggests not a very effective usage of assets in July.Axogen Ownership Allocation
Axogen holds a total of 45.54 Million outstanding shares. The majority of Axogen Inc outstanding shares are owned by other corporate entities. These outside corporations are usually referred to as non-private investors looking to acquire positions in Axogen Inc to benefit from reduced commissions. Consequently, institutional investors are subject to a different set of regulations than regular investors in Axogen. Please pay attention to any change in the institutional holdings of Axogen Inc as this could imply that something significant has changed or is about to change at the company. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.Axogen Profitability Analysis
The company reported the previous year's revenue of 187.34 M. Net Loss for the year was (9.96 M) with profit before overhead, payroll, taxes, and interest of 144.29 M.About Axogen Valuation
We use absolute and relative valuation methodologies to arrive at the intrinsic value of Axogen Inc. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of Axogen Inc based exclusively on its fundamental and basic technical indicators. By analyzing Axogen's financials, quarterly and monthly indicators, and their related drivers, we attempt to find the most accurate representation of Axogen's intrinsic value. As compared to an absolute model, our relative valuation model uses a comparative analysis of Axogen. We calculate exposure to Axogen's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Axogen's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | 142 M | 149.1 M | |
| Pretax Profit Margin | (0.05) | (0.06) | |
| Operating Profit Margin | (0.02) | (0.02) | |
| Net Loss | (0.05) | (0.06) | |
| Gross Profit Margin | 0.76 | 0.46 |
Axogen Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines.
| Common Stock Shares Outstanding | 44.3 M | |
| Forward Price Earnings | 41.841 |
Axogen Current Valuation Indicators
Axogen's valuation analysis is a process of estimating the intrinsic value of all assets and outstanding equities. There are different methodologies and models we use to develop the final Axogen's valuation. The techniques such as discounted cash flow and fundamental indicators such as book value per share or market capitalization are well known and widely used across most financial advisers and money managers.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as Axogen, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use Axogen's valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes Axogen's worth.When determining whether Axogen Inc offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Axogen's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Axogen Inc Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Axogen Inc Stock: Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Axogen Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price. You can also try the Efficient Frontier module to plot and analyze your portfolio and positions against risk-return landscape of the market..
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Axogen. If investors know Axogen will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Axogen listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.16) | Revenue Per Share | Quarterly Revenue Growth 0.174 | Return On Assets | Return On Equity |
The market value of Axogen Inc is measured differently than its book value, which is the value of Axogen that is recorded on the company's balance sheet. Investors also form their own opinion of Axogen's value that differs from its market value or its book value, called intrinsic value, which is Axogen's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Axogen's market value can be influenced by many factors that don't directly affect Axogen's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Axogen's value and its price as these two are different measures arrived at by different means. Investors typically determine if Axogen is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Axogen's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.